A Review on INFLUENCE OF GENETIC POLYMORPHISMS OF HUMAN CYTOCHROME P450 GENE (original) (raw)

Associate editor: H. Bönisch Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

天鹏 张

View PDFchevron_right

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

Ivar Roots

Pharmacogenomics, 2000

View PDFchevron_right

Cytochrome P450 enzyme polymorphisms and adverse drug reactions

Munir Pirmohamed

Toxicology, 2003

View PDFchevron_right

Cytochrome P450 – Role In Drug Metabolism And Genetic Polymorphism

Anitha Rajan

2018

View PDFchevron_right

Cytochrome P450 Part 2: Genetics of Inter-Individual Variability

Ross McKinnon

Journal of Pharmacy Practice and Research, 2008

View PDFchevron_right

Pharmacogenomic Role in Cytochrome P450 Enzymes-Mediated Metabolism for Drug Therapy

Linawati Hananta

Journal of Urban Health Research

View PDFchevron_right

Opportunities and obstacles in genotypic prediction of cytochrome P450 phenotypes

Joseph McGraw

Expert Opinion on Drug Metabolism & Toxicology, 2018

View PDFchevron_right

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem

Kathrin Klein

Frontiers in Genetics, 2013

View PDFchevron_right

Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism

Christopher Wesselman

Pharmacogenetics and Genomics, 2008

View PDFchevron_right

Genetic Variations in Cytochrome P450 2C9 and 2C19: A Review

abdoljalal marjani

Current Pharmacogenomics and Personalized Medicine, 2017

View PDFchevron_right

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

Kathrin Klein

Analytical and Bioanalytical Chemistry, 2008

View PDFchevron_right

Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk

Mila Lovrić

Archives of Industrial Hygiene and Toxicology, 2009

View PDFchevron_right

Estimation of Drug-Metabolizing Capacity by Cytochrome P450 Genotyping and Expression

E. Sarvary

Journal of Pharmacology and Experimental Therapeutics, 2012

View PDFchevron_right

Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms

Marjolein Drent

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

Kathrin Klein

Frontiers in Genetics, 2013

View PDFchevron_right

Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression

José Rueff

The Pharmacogenomics Journal, 2010

View PDFchevron_right

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan

Kholood Janjua

PeerJ

View PDFchevron_right

Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism

adriana isvoran

Drug Discovery Today, 2017

View PDFchevron_right

Pharmacogenetics of cytochrome P450 (CYP) in the elderly

Andrea Pilotto

Ageing Research Reviews, 2010

View PDFchevron_right

Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes

Lei Shen

2011

View PDFchevron_right

Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy

Robert Preissner

PLoS ONE, 2013

View PDFchevron_right

Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs

Giulia Paroni

Clinical laboratory, 2011

View PDFchevron_right

Cytochrome P450 3A pharmacogenetics: the road that needs traveled

James Rae

The Pharmacogenomics Journal, 2003

View PDFchevron_right

Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing

Kristine Ashcraft

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016

View PDFchevron_right

Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects

Zahurin Mohamed

British Journal of Clinical Pharmacology, 2004

View PDFchevron_right

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

Sebastian Raimundo

Naunyn-Schmiedeberg's Archives of Pharmacology, 2004

View PDFchevron_right

Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity

Guido Haenen

Drug Safety, 2008

View PDFchevron_right

Cytochrome P450 2D6 (CYP2D6) Genotype and Phenotype Determination in the

Benjamin Ebeshi

View PDFchevron_right

Bench to Bedside: Pharmacogenomics, Adverse Drug Interactions, and the Cytochrome P450 System

Andrew Ulrich

Academic Emergency Medicine, 2005

View PDFchevron_right

Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations

Ahmed Rebai

Journal of Genetics, 2015

View PDFchevron_right